Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cuthbertson

Showing results (51-60 of 146) with videos related to

Pageof 15
Sort By:
Diabetologia|January 9, 2020
Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes: the TRIGR nested case-control ancillary studyMaija E Miettinen, Sari Niinistö, Iris Erlund, et al.
Pediatric Diabetes|June 11, 2004
Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?Desmond Schatz, David Cuthbertson, Mark Atkinson, et al.
Diabetes Technology & Therapeutics|January 6, 2025
A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive CohortsJay M Sosenko, David Cuthbertson, Laura M Jacobsen, et al.
Annals of the Rheumatic Diseases|December 11, 2013
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)Carol A Langford, Paul A Monach, Ulrich Specks, et al.
Diabetes|August 5, 2010
Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1)Jay M Sosenko, Jay S Skyler, Jeffrey P Krischer, et al.
Diabetes|April 2, 2025
The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 DiabetesHeba M Ismail, David Cuthbertson, Alfonso Galderisi, et al.
The Journal of Nutrition|June 21, 2024
High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes-The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) StudySari Niinistö, David Cuthbertson, Maija E Miettinen, et al.
Clinical Genetics|February 13, 2021
Health-related quality of life in adults with osteogenesis imperfectaChaya N Murali, Brady Slater, Salma Musaad, et al.
Pediatric Diabetes|June 5, 2010
A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participantsJay M Sosenko, Jeffrey Mahon, Lisa Rafkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2010
Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromesMikkael A Sekeres, Alan F List, David Cuthbertson, et al.
Pageof 15

Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
Diabetologia|January 9, 2020
Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes: the TRIGR nested case-control ancillary studyMaija E Miettinen, Sari Niinistö, Iris Erlund, et al.
Pediatric Diabetes|June 11, 2004
Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?Desmond Schatz, David Cuthbertson, Mark Atkinson, et al.
Diabetes Technology & Therapeutics|January 6, 2025
A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive CohortsJay M Sosenko, David Cuthbertson, Laura M Jacobsen, et al.
Annals of the Rheumatic Diseases|December 11, 2013
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)Carol A Langford, Paul A Monach, Ulrich Specks, et al.
Diabetes|August 5, 2010
Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1)Jay M Sosenko, Jay S Skyler, Jeffrey P Krischer, et al.
Diabetes|April 2, 2025
The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 DiabetesHeba M Ismail, David Cuthbertson, Alfonso Galderisi, et al.
The Journal of Nutrition|June 21, 2024
High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes-The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) StudySari Niinistö, David Cuthbertson, Maija E Miettinen, et al.
Clinical Genetics|February 13, 2021
Health-related quality of life in adults with osteogenesis imperfectaChaya N Murali, Brady Slater, Salma Musaad, et al.
Pediatric Diabetes|June 5, 2010
A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participantsJay M Sosenko, Jeffrey Mahon, Lisa Rafkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2010
Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromesMikkael A Sekeres, Alan F List, David Cuthbertson, et al.
Pageof 15